Bank of America’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.95B | Sell |
3,895,265
-1,638,138
| -30% | -$786M | 0.13% | 161 |
|
|
2026
Q1 | $2.72B | Sell |
5,533,403
-412,435
| -7% | -$224M | 0.2% | 101 |
|
|
2025
Q4 | $3.45B | Buy |
5,945,838
+575,139
| +11% | +$325M | 0.25% | 79 |
|
|
2025
Q3 | $2.6B | Buy |
5,370,699
+1,445,375
| +37% | +$673M | 0.18% | 116 |
|
|
2025
Q2 | $1.59B | Sell |
3,925,324
-34,375
| -0.9% | -$14.4M | 0.12% | 173 |
|
|
2025
Q1 | $1.97B | Sell |
3,959,699
-86,477
| -2% | -$46.8M | 0.16% | 132 |
|
|
2024
Q4 | $2.1B | Sell |
4,046,176
-1,652,951
| -29% | -$909M | 0.18% | 119 |
|
|
2024
Q3 | $3.53B | Buy |
5,699,127
+54,563
| +1% | +$32.3M | 0.28% | 74 |
|
|
2024
Q2 | $3.12B | Buy |
5,644,564
+559,045
| +11% | +$320M | 0.28% | 71 |
|
|
2024
Q1 | $2.96B | Buy |
5,085,519
+184,745
| +4% | +$104M | 0.27% | 78 |
|
|
2023
Q4 | $2.6B | Sell |
4,900,774
-652,814
| -12% | -$316M | 0.26% | 82 |
|
|
2023
Q3 | $2.81B | Buy |
5,553,588
+283,224
| +5% | +$151M | 0.31% | 71 |
|
|
2023
Q2 | $2.75B | Sell |
5,270,364
-268,671
| -5% | -$145M | 0.29% | 75 |
|
|
2023
Q1 | $3.19B | Sell |
5,539,035
-589,829
| -10% | -$332M | 0.33% | 67 |
|
|
2022
Q4 | $3.38B | Buy |
6,128,864
+299,569
| +5% | +$159M | 0.38% | 50 |
|
|
2022
Q3 | $2.96B | Buy |
5,829,295
+108,492
| +2% | +$60.7M | 0.35% | 53 |
|
|
2022
Q2 | $3.11B | Sell |
5,720,803
-1,886
| -0% | -$1.04M | 0.35% | 58 |
|
|
2022
Q1 | $3.38B | Sell |
5,722,689
-56,212
| -1% | -$32.3M | 0.33% | 63 |
|
|
2021
Q4 | $3.86B | Sell |
5,778,901
-78,424
| -1% | -$49M | 0.37% | 52 |
|
|
2021
Q3 | $3.35B | Buy |
5,857,325
+70,073
| +1% | +$38.5M | 0.35% | 56 |
|
|
2021
Q2 | $2.92B | Sell |
5,787,252
-475,404
| -8% | -$224M | 0.3% | 70 |
|
|
2021
Q1 | $2.86B | Sell |
6,262,656
-426,349
| -6% | -$203M | 0.32% | 65 |
|
|
2020
Q4 | $3.12B | Sell |
6,689,005
-700,263
| -9% | -$328M | 0.4% | 54 |
|
|
2020
Q3 | $3.26B | Buy |
7,389,268
+76,273
| +1% | +$31.5M | 0.44% | 45 |
|
|
2020
Q2 | $2.65B | Buy |
7,312,995
+258,260
| +4% | +$86.6M | 0.4% | 47 |
|
|
2020
Q1 | $2B | Buy |
7,054,735
+168,976
| +2% | +$53.3M | 0.36% | 61 |
|
|
2019
Q4 | $2.24B | Sell |
6,885,759
-60,355
| -0.9% | -$18.3M | 0.32% | 78 |
|
|
2019
Q3 | $2.02B | Buy |
6,946,114
+115,295
| +2% | +$33M | 0.3% | 81 |
|
|
2019
Q2 | $2.01B | Buy |
6,830,819
+71,193
| +1% | +$19.6M | 0.3% | 81 |
|
|
2019
Q1 | $1.85B | Buy |
6,759,626
+57,475
| +0.9% | +$14.3M | 0.29% | 78 |
|
|
2018
Q4 | $1.5B | Sell |
6,702,151
-120,055
| -2% | -$28.2M | 0.26% | 85 |
|
|
2018
Q3 | $1.67B | Buy |
6,822,206
+393,649
| +6% | +$90.6M | 0.26% | 88 |
|
|
2018
Q2 | $1.33B | Buy |
6,428,557
+204,913
| +3% | +$43.5M | 0.22% | 104 |
|
|
2018
Q1 | $1.28B | Sell |
6,223,644
-489,031
| -7% | -$103M | 0.22% | 111 |
|
|
2017
Q4 | $1.27B | Sell |
6,712,675
-553,804
| -8% | -$106M | 0.21% | 113 |
|
|
2017
Q3 | $1.37B | Buy |
7,266,479
+741,625
| +11% | +$134M | 0.22% | 116 |
|
|
2017
Q2 | $1.14B | Sell |
6,524,854
-360,540
| -5% | -$60.6M | 0.23% | 114 |
|
|
2017
Q1 | $1.06B | Sell |
6,885,394
-137,115
| -2% | -$21M | 0.21% | 116 |
|
|
2016
Q4 | $991M | Buy |
7,022,509
+448,046
| +7% | +$66.1M | 0.21% | 113 |
|
|
2016
Q3 | $1.05B | Sell |
6,574,463
-25,573
| -0.4% | -$3.94M | 0.23% | 103 |
|
|
2016
Q2 | $975M | Sell |
6,600,036
-184,547
| -3% | -$27.2M | 0.23% | 110 |
|
|
2016
Q1 | $961M | Sell |
6,784,583
-651,875
| -9% | -$87.4M | 0.23% | 104 |
|
|
2015
Q4 | $1.05B | Buy |
7,436,458
+294,106
| +4% | +$39.2M | 0.25% | 101 |
|
|
2015
Q3 | $873M | Buy |
7,142,352
+3,154,945
| +79% | +$411M | 0.22% | 112 |
|
|
2015
Q2 | $517M | Sell |
3,987,407
-81,638
| -2% | -$10.6M | 0.17% | 134 |
|
|
2015
Q1 | $547M | Sell |
4,069,045
-212,526
| -5% | -$27.4M | 0.18% | 125 |
|
|
2014
Q4 | $536M | Sell |
4,281,571
-125,384
| -3% | -$15.2M | 0.19% | 110 |
|
|
2014
Q3 | $536M | Sell |
4,406,955
-94,626
| -2% | -$11.5M | 0.17% | 122 |
|
|
2014
Q2 | $531M | Buy |
4,501,581
+797,276
| +22% | +$93.8M | 0.17% | 130 |
|
|
2014
Q1 | $445M | Sell |
3,704,305
-1,034,226
| -22% | -$123M | 0.17% | 132 |
|
|
2013
Q4 | $528M | Buy |
4,738,531
+306,580
| +7% | +$30.5M | 0.19% | 111 |
|
|
2013
Q3 | $408M | Buy |
4,431,951
+330,945
| +8% | +$29.9M | 0.16% | 130 |
|
|
2013
Q2 | $347M | Buy |
+4,101,006
| New | +$341M | 0.15% | 142 |
|
Other funds holding TMO
Bank of America's TMO Position: Q2 2026 in Review
Bank of America reduced its Thermo Fisher Scientific (TMO) stake by 30% in Q2 2026, selling an estimated $786M and leaving 3,895,265 shares worth $1.95B. The position accounts for 0.13% of the portfolio, ranked #161.
Bank of America first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.86B in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Bank of America held 3,895,265 shares of Thermo Fisher Scientific worth $1.95B as of Q2 2026.
- Bank of America sold 1,638,138 Thermo Fisher Scientific shares in Q2 2026, an estimated $786M.
- Thermo Fisher Scientific made up 0.13% of Bank of America's portfolio in Q2 2026, its #161 holding.
- Bank of America first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Bank of America's Thermo Fisher Scientific position peaked at $3.86B in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.